Literature DB >> 24365767

Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale.

Sarah Elizabeth Gilpin1, Jacques P Guyette1, Gabriel Gonzalez1, Xi Ren1, John M Asara1, Douglas J Mathisen1, Joseph P Vacanti2, Harald C Ott3.   

Abstract

BACKGROUND: Organ engineering is a theoretical alternative to allotransplantation for end-stage organ failure. Whole-organ scaffolds can be created by detergent perfusion via the native vasculature, generating an acellular matrix suitable for recellularization with selected cell types. We aimed to up-scale this process, generating biocompatible scaffolds of a clinically relevant scale.
METHODS: Rat, porcine, and human lungs were decellularized by detergent perfusion at constant pressures. Collagen, elastin, and glycosaminoglycan content of scaffolds were quantified by colorimetric assays. Proteomic analysis was performed by microcapillary liquid chromatography tandem mass spectrometry. Extracellular matrix (ECM) slices were cultured with human umbilical vein endothelial cells (HUVEC), small airway epithelial cells (SAEC), or pulmonary alveolar epithelial cells (PAECs) and evaluated by time-lapse live cell microscopy and MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay. Whole-organ culture was maintained under constant-pressure media perfusion after seeding with PAECs.
RESULTS: Rat lungs were decellularized using: (1) sodium dodecyl sulfate (SDS), (2) sodium deoxycholate (SDC), or (3) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS). Resulting scaffolds showed comparable loss of DNA but greatest preservation of ECM components in SDS-decellularized lungs. Porcine (n = 10) and human (n = 7) lungs required increased SDS concentration, perfusion pressures, and time to achieve decellularization as determined by loss of DNA, with preservation of intact matrix composition and lung architecture. Proteomic analysis of human decellularized lungs further confirmed ECM preservation. Recellularization experiments confirmed scaffold biocompatibility when cultured with mature cell phenotypes and scaffold integrity for the duration of biomimetic culture.
CONCLUSIONS: SDS-based perfusion decellularization can be applied to whole porcine and human lungs to generate biocompatible organ scaffolds with preserved ECM composition and architecture.
© 2013 International Society for Heart and Lung Transplantation Published by International Society for the Heart and Lung Transplantation All rights reserved.

Entities:  

Keywords:  acellular matrix; decellularization; organ engineering; organ scaffolds; recellularization

Mesh:

Substances:

Year:  2013        PMID: 24365767     DOI: 10.1016/j.healun.2013.10.030

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  82 in total

1.  Production of decellularized porcine lung scaffolds for use in tissue engineering.

Authors:  Jenna L Balestrini; Ashley L Gard; Angela Liu; Katherine L Leiby; Jonas Schwan; Britta Kunkemoeller; Elizabeth A Calle; Amogh Sivarapatna; Tylee Lin; Sashka Dimitrievska; Stuart G Cambpell; Laura E Niklason
Journal:  Integr Biol (Camb)       Date:  2015-10-01       Impact factor: 2.192

2.  A Rotating Bioreactor for Scalable Culture and Differentiation of Respiratory Epithelium.

Authors:  Micha Sam Brickman Raredon; Mahboobe Ghaedi; Elizabeth A Calle; Laura E Niklason
Journal:  Cell Med       Date:  2014-12-12

3.  Bioreactor Development for Lung Tissue Engineering.

Authors:  Angela Panoskaltsis-Mortari
Journal:  Curr Transplant Rep       Date:  2015-03

4.  Residual Detergent Detection Method for Nondestructive Cytocompatibility Evaluation of Decellularized Whole Lung Scaffolds.

Authors:  Barbora Zvarova; Franziska E Uhl; Juan J Uriarte; Zachary D Borg; Amy L Coffey; Nicholas R Bonenfant; Daniel J Weiss; Darcy E Wagner
Journal:  Tissue Eng Part C Methods       Date:  2016-03-29       Impact factor: 3.056

5.  Quantification of decellularized human myocardial matrix: A comparison of six patients.

Authors:  Todd D Johnson; Ryan C Hill; Monika Dzieciatkowska; Vishal Nigam; Atta Behfar; Karen L Christman; Kirk C Hansen
Journal:  Proteomics Clin Appl       Date:  2015-09-28       Impact factor: 3.494

6.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

7.  Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration.

Authors:  Sarah E Gilpin; Qiyao Li; Daniele Evangelista-Leite; Xi Ren; Dieter P Reinhardt; Brian L Frey; Harald C Ott
Journal:  Biomaterials       Date:  2017-06-22       Impact factor: 12.479

8.  Crossing kingdoms: Using decellularized plants as perfusable tissue engineering scaffolds.

Authors:  Joshua R Gershlak; Sarah Hernandez; Gianluca Fontana; Luke R Perreault; Katrina J Hansen; Sara A Larson; Bernard Y K Binder; David M Dolivo; Tianhong Yang; Tanja Dominko; Marsha W Rolle; Pamela J Weathers; Fabricio Medina-Bolivar; Carole L Cramer; William L Murphy; Glenn R Gaudette
Journal:  Biomaterials       Date:  2017-02-10       Impact factor: 12.479

9.  Regenerative potential of human airway stem cells in lung epithelial engineering.

Authors:  Sarah E Gilpin; Jonathan M Charest; Xi Ren; Luis F Tapias; Tong Wu; Daniele Evangelista-Leite; Douglas J Mathisen; Harald C Ott
Journal:  Biomaterials       Date:  2016-09-04       Impact factor: 12.479

10.  Comparative decellularization and recellularization of normal versus emphysematous human lungs.

Authors:  Darcy E Wagner; Nicholas R Bonenfant; Charles S Parsons; Dino Sokocevic; Elice M Brooks; Zachary D Borg; Melissa J Lathrop; John D Wallis; Amanda B Daly; Ying Wai Lam; Bin Deng; Michael J DeSarno; Takamaru Ashikaga; Roberto Loi; Daniel J Weiss
Journal:  Biomaterials       Date:  2014-01-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.